A new 10-year longitudinal study published in Translational Psychiatry is examining how cannabis use patterns intersect with changing levels of depression and the risk of suicide attempts over time. The research, led by Maffre Maviel, G. Davisse-Paturet, A. Duclos and colleagues, focuses on a question that has become increasingly important in public health: whether the relationship between cannabis and suicidal behavior depends not simply on whether a person uses cannabis, but on when, how often and for how long that use occurs.
The study’s central strength is its longitudinal design. Unlike a one-time survey, which captures behavior and mental health at a single moment, a 10-year study follows participants across an extended period. This allows researchers to examine temporal sequences—whether cannabis use precedes worsening depressive symptoms, whether depression is followed by increased cannabis use, or whether both develop in response to other psychological or social pressures. Such patterns are critical because associations observed at one time point cannot establish which factor came first.
Rather than treating cannabis use as a simple yes-or-no variable, the research considers “use patterns.” In epidemiology, this approach can distinguish among people who never use cannabis, those who experiment occasionally, those whose use becomes frequent, and those whose consumption changes over time. A trajectory-based framework may also identify participants whose use begins early, persists for years or escalates during periods of emotional distress. These distinctions can reveal risks that would otherwise be hidden inside a single average estimate.
The study also follows depression as a trajectory rather than as a fixed diagnosis. Depressive symptoms can remain low, emerge temporarily, recur in episodes or gradually intensify. Statistical models designed to analyze trajectories can group individuals according to these patterns and then compare their histories of cannabis use and suicide attempts. This is technically different from asking whether cannabis users are more depressed than non-users. It examines how mental health evolves, and whether particular combinations of cannabis exposure and depressive symptoms are linked to more serious outcomes.
Suicide attempts are treated as a distinct outcome because they represent a critical escalation beyond suicidal thoughts or general psychological distress. They are also relatively uncommon events in population studies, which makes careful follow-up essential. Researchers must account for the timing of attempts, repeated events and the possibility that participants may not report them consistently. A decade of observation can improve the chance of identifying meaningful patterns, while statistical adjustment can help separate the relationship of cannabis and depression from other factors associated with suicide risk.
The findings are relevant to a long-running debate about cannabis and mental health. Cannabis contains psychoactive compounds, most notably delta-9-tetrahydrocannabinol, or THC, which can affect memory, reward processing, anxiety and emotional regulation. The effects vary according to dose, potency, frequency of use, age at first exposure and individual vulnerability. Cannabidiol, or CBD, has different pharmacological properties, meaning that “cannabis use” is not a chemically uniform exposure. The study’s emphasis on patterns therefore reflects a broader shift toward more precise mental-health research.
At the same time, the researchers’ approach is important because cannabis use and depression may influence one another. People experiencing depressive symptoms may use cannabis in an attempt to relieve anxiety, numb emotional pain or improve sleep. In some individuals, however, frequent use may be followed by impaired motivation, disrupted sleep, withdrawal symptoms or greater emotional instability. This feedback loop is known as bidirectionality: cannabis may affect mental health, while mental health may also affect cannabis use. A longitudinal analysis is better equipped than a cross-sectional survey to investigate this possibility, although it cannot eliminate every source of bias.
The study cannot, by its design alone, prove that cannabis causes depression or suicide attempts. Even sophisticated statistical analyses may be affected by confounding variables, including family history of mental illness, trauma, socioeconomic conditions, alcohol or other drug use, access to mental-health care and changes in social circumstances. Researchers can measure and adjust for some of these influences, but unmeasured factors may remain. The most scientifically responsible interpretation is therefore one of risk association and developmental pattern, not a universal cause-and-effect rule applying to every cannabis user.
The implications for clinical care and prevention are nevertheless substantial. If particular combinations of persistent cannabis use and worsening depressive symptoms are associated with greater suicide-attempt risk, clinicians may benefit from screening for both conditions together rather than assessing them separately. A young person reporting frequent cannabis use, sleep disruption and a sustained decline in mood may require a more detailed evaluation than a brief substance-use question can provide. Early identification could support counseling, evidence-based treatment for depression and timely suicide-risk assessment. The study reinforces the need for nuanced, nonjudgmental conversations about cannabis, mental health and safety.
As cannabis policies and products continue to change, evidence from long-term population research is increasingly valuable. Public discussion often swings between portraying cannabis as harmless and presenting it as uniformly dangerous, but human behavior and biology rarely fit either extreme. The 10-year analysis by Maffre Maviel and colleagues contributes to a more detailed picture by connecting patterns of exposure with trajectories of depression and serious suicidal behavior. Its greatest message is not that one factor explains suicide risk, but that mental health outcomes emerge over time through interacting biological, psychological and social processes.
Subject of Research: Cannabis use patterns, depression trajectories, and suicide attempts over a 10-year period.
Article Title: Cannabis use patterns, depression trajectories and suicide attempts: a 10-year longitudinal study
Article References: Maffre Maviel, G., Davisse-Paturet, C., Duclos, A. et al. Cannabis use patterns, depression trajectories and suicide attempts: a 10-year longitudinal study. Transl Psychiatry (2026). https://doi.org/10.1038/s41398-026-04344-4
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41398-026-04344-4
Keywords: cannabis, depression, suicide attempts, mental health, longitudinal study, epidemiology, substance use, psychiatric research, suicide prevention
